Increasing incidence of bullous pemphigoid in Northern Finland: A retrospective database study in Oulu University Hospital

British Journal of Dermatology

Volumn 171, Issue 5, 2014, Pages 1223-1226

  Forsti A K ^a   Jokelainen, J ^a   Timonen, M ^b   Tasanen, K ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BULLOUS PEMPHIGOID; CHILD; CLINICAL FEATURE; DATA BASE; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FINLAND; HUMAN; IMMUNOFLUORESCENCE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SKIN BIOPSY; STANDARDIZATION; UNIVERSITY HOSPITAL; AGE DISTRIBUTION; MIDDLE AGED; ONSET AGE; PEMPHIGOID, BULLOUS; SEX RATIO; VERY ELDERLY;

ADULT; AGE DISTRIBUTION; AGE OF ONSET; AGED; AGED, 80 AND OVER; FEMALE; FINLAND; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PEMPHIGOID, BULLOUS; RETROSPECTIVE STUDIES; SEX DISTRIBUTION;

EID: 84911418664     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.13189     Document Type: Article

References (17)

1. Schmidt E, Zillikens D,. Pemphigoid diseases. Lancet 2013; 381: 320-32.
2. Bernard P, Vaillant L, Labeille B, et al,. Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Arch Dermatol 1995; 131: 48-52.
3. Zillikens D, Wever S, Roth A, et al,. Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany. Arch Dermatol 1995; 131: 957-8.
4. Jung M, Kippes W, Messer G, et al,. Increased risk of bullous pemphigoid in male and very old patients: a population-based study on incidence. J Am Acad Dermatol 1999; 41: 266-8.
5. Wong SN, Chua SH,. Spectrum of subepidermal immunobullous disorders seen at the National Skin Centre, Singapore: a 2-year review. Br J Dermatol 2002; 147: 476-80.
6. Gudi VS, White MI, Cruickshank N, et al,. Annual incidence and mortality of bullous pemphigoid in the Grampian Region of North-East Scotland. Br J Dermatol 2005; 153: 424-7.
7. Langan SM, Smeeth L, Hubbard R, et al,. Bullous pemphigoid and pemphigus vulgaris-incidence and mortality in the U.K.: population based cohort study. BMJ 2008; 337: a180.
8. Marazza G, Pham HC, Schärer L, et al,. Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study. Br J Dermatol 2009; 161: 861-8.
9. Joly P, Baricault S, Sparsa A, et al,. Incidence and mortality of bullous pemphigoid in France. J Invest Dermatol 2012; 132: 1998-2004.
10. Baican A, Baican C, Chiriac G, et al,. Pemphigus vulgaris is the most common autoimmune bullous disease in Northwestern Romania. Int J Dermatol 2010; 49: 768-74.
11. Wojnarowska F, Kirtschig G, Highet AS, et al,. Guidelines for the management of bullous pemphigoid. Br J Dermatol 2002; 147: 214-21.
12. Venning VA, Taghipour K, Mohd Mustapa MF, et al,. British Association of Dermatologists' guidelines for the management of bullous pemphigoid 2012. Br J Dermatol 2012; 167: 1200-14.
13. Weiskopf D, Weinberger B, Grubeck-Loebenstein B,. The aging of the immune system. Transpl Int 2009; 22: 1041-50.
14. Bastuji-Garin S, Joly P, Lemordant P, et al,. Risk factors for bullous pemphigoid in the elderly: a prospective case-control study. J Invest Dermatol 2011; 131: 637-43.
15. Stavropoulos PG, Soura E, Antoniou C,. Drug-induced pemphigoid: a review of the literature. J Eur Acad Dermatol Venereol 2014; 28: 1133-40.
16. Bertram F, Bröcker E-B, Zillikens D, Schmidt E,. Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany. J Dtsch Dermatol Ges 2009; 7: 434-40.
17. Naldi L, Cazzaniga S, Borradori L,. Bullous pemphigoid: simple measures for a complex disease. J Invest Dermatol 2012; 132: 1948-50.